These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12197595)

  • 1. Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy.
    Iwai C; Akita H; Shiga N; Takai E; Miyamoto Y; Shimizu M; Kawai H; Takarada A; Kajiya T; Yokoyama M
    Circ J; 2002 Aug; 66(8):723-8. PubMed ID: 12197595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
    Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension.
    Bengtsson K; Melander O; Orho-Melander M; Lindblad U; Ranstam J; Råstam L; Groop L
    Circulation; 2001 Jul; 104(2):187-90. PubMed ID: 11447084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β1-Adrenergic receptor Arg389Gly polymorphism affects the antiarrhythmic efficacy of flecainide in patients with coadministration of β-blockers.
    Doki K; Sekiguchi Y; Kuga K; Aonuma K; Homma M
    Pharmacogenet Genomics; 2016 Oct; 26(10):481-5. PubMed ID: 27500822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the beta-1 adrenergic receptor carboxyl terminal variants with left ventricular hypertrophy among diabetic and non-diabetic survivors of acute myocardial infarction.
    Hakalahti AE; Tapanainen JM; Junttila JM; Kaikkonen KS; Huikuri HV; Petäjä-Repo UE
    Cardiovasc Diabetol; 2010 Aug; 9():42. PubMed ID: 20731869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis.
    Liu WN; Fu KL; Gao HY; Shang YY; Wang ZH; Jiang GH; Zhang Y; Zhang W; Zhong M
    PLoS One; 2012; 7(7):e37659. PubMed ID: 22815685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
    Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
    Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
    Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Arg389Gly β1-adrenoceptor gene polymorphism influences the acute effects of β-adrenoceptor blockade on contractility in the human heart.
    Huntgeburth M; La Rosée K; ten Freyhaus H; Böhm M; Schnabel P; Hellmich M; Rosenkranz S
    Clin Res Cardiol; 2011 Aug; 100(8):641-7. PubMed ID: 21311897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
    Yu WP; Lou M; Deng B; Song HM; Wang HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
    Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
    Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markedly reduced effects of (-)-isoprenaline but not of (-)-CGP12177 and unchanged affinity of beta-blockers at Gly389-beta1-adrenoceptors compared to Arg389-beta1-adrenoceptors.
    Joseph SS; Lynham JA; Grace AA; Colledge WH; Kaumann AJ
    Br J Pharmacol; 2004 May; 142(1):51-6. PubMed ID: 15037517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial beta1-adrenergic receptor polymorphisms affect functional recovery after ischemic injury.
    Akhter SA; D'Souza KM; Petrashevskaya NN; Mialet-Perez J; Liggett SB
    Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1427-32. PubMed ID: 16537791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arg389Gly polymorphism of the human beta1-adrenergic receptor in patients with nonfatal acute myocardial infarction.
    Iwai C; Akita H; Kanazawa K; Shiga N; Terashima M; Matsuda Y; Takai E; Miyamoto Y; Shimizu M; Kajiya T; Hayashi T; Yokoyama M
    Am Heart J; 2003 Jul; 146(1):106-9. PubMed ID: 12851615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta1- and alpha2c-adrenoreceptor variants as predictors of clinical aspects of dilated cardiomyopathy in people of African ancestry.
    Woodiwiss AJ; Badenhorst D; Sliwa K; Brooksbank R; Essop R; Sareli P; Norton GR
    Cardiovasc J Afr; 2008; 19(4):188-93. PubMed ID: 18776959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Arg389Gly beta1-adrenoceptor polymorphism does not affect cardiac effects of exercise after parasympathetic inhibition by atropine.
    Leineweber K; Bruck H; Temme T; Heusch G; Philipp T; Brodde OE
    Pharmacogenet Genomics; 2006 Jan; 16(1):9-13. PubMed ID: 16344717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathy.
    Fragoso JM; Rodríguez-Pérez JM; González J; Cruz D; Pérez-Méndez O; de Jesus García J; de la Peña A; Arce M; Reyes PA; Vargas-Alarcón G
    Exp Mol Pathol; 2006 Jun; 80(3):279-82. PubMed ID: 16487965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure].
    Moraga F; Troncoso R; Mellado R; Díaz-Araya G; Vukasovic JL; Greig D; Perez O; García L; Roldán J; Ocaranza MP; Jali J; Chiong M; Castro P
    Rev Med Chil; 2008 Nov; 136(11):1371-80. PubMed ID: 19301767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.